Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Overview
The report on the isothermal nucleic acid amplification technology (INAAT) market presents a global scale study. It provides insights into the factors favoring the development of novel applications of nucleic acid in nanoparticle diagnostics, molecular diagnostics, and laboratory research. It is compiled with the intent of highlighting the prevailing dynamics and growth opportunities in the global isothermal nucleic acid amplification technology market. Information thus included in the report will help stakeholders get a better perspective of the market.
By the standards of the World Health Organization (WHO), an ideal RNA/DNA diagnostic test kit, which usually includes polymerase chain reaction (PCR) instruments, should be accurate, cost-effective, and customization to cater to specific user requirements. Furthermore, it is necessary for the diagnostic test kits to be less complicated and tough at the same time. All in all, the demand for instruments providing quick and precise results of diagnosis is considerably high.
Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=994
Given the aforementioned requirements, despite providing practical solutions, the currently available nucleic acid diagnostic technology is unable to fulfil the low-cost requirements and thus fails to achieve any organization’s assurance. The advent of non-PCR technology such as INAAT is thus gaining traction from the research community as it complies with all criteria specific by the WHO. With a little tinkering in the parameters, INAAT can be customized to suit different measurement requirements, thereby facilitating Point-of-Care testing (POCT), while operating within economic standards set by the WHO.
The report studies the growth trajectory of the global INAAT market between 2016 and 2024. The growth drivers and restraints influencing the market over the course of the forecast period. The impact of the latest government policies and the prevalent socio-economic conditions in the overall market is also gauged. It studies the effect of Porter’s five forces in the global INAAT market considering the bargaining power of suppliers and buyers, prevailing degree of competition, and threat of substitute and new entrants.
Request Customization on Isothermal Nucleic Acid Amplification Technology Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=994
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Drivers and Restraints
In the global isothermal nucleic acid amplification technology market, growth witnessed in the molecular diagnostics segment in the healthcare industry, has emerged as a key driver. The molecular diagnostic market comprises INAAT and PCR. Of these, the INAAT based on type include helicase dependent application (HAD), loop-mediated isothermal amplification (LAMP), strand displacement amplification (SDA), nucleic acid sequence based amplification (NASBA), transcription mediated amplification (TMA), and single primer isothermal amplification (SPIA).
Despite witnessing positive opportunities worldwide, lack of awareness about the advanced diagnostics, especially in underdeveloped economies is acting as a major restraint for the market. It is due to the same factor, that manufacturers are unable to capitalize on the high unmet medical needs in underdeveloped countries. Furthermore, stringent regulations imposed by organizations such as the WHO and certain reluctance to replace the existing PCR solutions with advanced methods in developing nations is posing threat to the global isothermal nucleic acid amplification technology market.
Pre Book Isothermal Nucleic Acid Amplification Technology Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=994<ype=S
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Regional Outlook
Regionally, North America, Asia Pacific, Europe, and Rest of the World (RoW) are the key segments in the global INAAT market. The growth witnessed in the market is majorly driven by the rising demand across the emerging economies in the Middle East and North America (MENA, Asia Pacific, and Rest of the World. The increasing investment in the healthcare industry and the rising awareness about low-cost and effective diagnosis will boost the global INAAT market.
The report presents insights into the growth drivers and restraints impacting the market’s growth across the key regional segments. It also identifies the threats and opportunities prevalent in the regional market, to help companies operating therein gain stronghold.
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Vendor Landscape
To study the vendor landscape, the report includes profiles of companies such as bioMerieux, Sharp Corp., Sony Corp., Panasonic, Toshiba Corp., Rohm, PhilipsHologic-Gen-Probe, BetaLED, Avago Technologies, BD Diagnostics, Meridian Bioscience, Eiken Chemical Co. Ltd., Qiagen, Alere, and BioHelix and Quidel.
The presence of large number of companies has rendered the market’s competitive landscape highly competitive. However, manufacturers in this market can expect high dividends by leveraging strategic decisions through collaborations and tie-ups, licensing, and agreements with research institutes with regards to the development of novel INAAT platforms. Furthermore, the manufacturers can gain from acquisition and other marketing strategies aimed at strengthening their position.
About Us Section:
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/
Factors such as the rising prevalence of infectious diseases and the introduction of newer pathogens, the need for prompt diagnosis, the increasing number of blood transfusions and donations, and the cost-benefits of INAAT are the key factors driving the market growth.The Isothermal Nucleic Acid Amplification Technology/INAAT Market is expected to grow from USD 1.9 billion in 2019 to USD 3.3 billion by 2024, at a CAGR of 11.0% during the forecast period.Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=839Market Segmentations:-Based on the product, the INAAT market is segmented into assay, kits, and reagents, and systems.
Assay, kits, and reagents segment are expected to account for the largest share of the INAAT industry in 2019, Based on the type, the global market is divided into TMA, LAMP, SDA, HAD, NASBA, and other technologies.Based on application, the INAAT market is segmented into infectious disease diagnosis, blood screening, and other applications such as cancer diagnosis, cancer research, and laboratory research, which encompass cDNA preparation, whole-genome amplification (WGA), single-nucleotide polymorphism (SNP), and mutation analysis.Based on the end user, the market is divided into hospitals, reference laboratories, academic and research institutes, and other end users.Recent Developments:In 2019, Hologic (US) launched Aptima BV and Aptima CV/TV AssaysIn 2018, Grifols (Spain) ) launched Procleix Babesia assayIn 2018, Tecan Trading AG (Switzerland) acquired Nugen Technologies (US) which helped the company to enhance its next-generation sequencing reagents portfolio.
This development helped the company to accelerate its broad genomics strategy.In 2016, Eiken Chemicals (Japan) signed a distribution agreement with HUMAN (Germany), for distribution of loop-mediated isothermal amplification-based tuberculosis and malaria molecular diagnostic systems in the global market (except in Japan, China, Korea, Taiwan, and Thailand).Regional Analysis:-In 2019, North America is expected to account for the largest share of the global INAAT market, followed by Europe.Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=839Top Key Players:-The major companies in the global INAAT market include Grifols S.A. (Spain), Hologic, Inc. (US), Abbott Laboratories, Inc. (US), Becton, Dickinson & Company (US), and Meridian Bioscience (US).
Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports The Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2020-30 by The Business Research Company describes and explains the global isothermal nucleic acid amplification technology market and covers 2015 to 2020, termed the historic period, and 2020 to 2025, termed the forecast period, along with further forecasts for the period 2025-2030.
The Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2021 covers isothermal nucleic acid amplification technology market drivers, isothermal nucleic acid amplification technology market trends, isothermal nucleic acid amplification technology market segments, isothermal nucleic acid amplification technology market growth rate, isothermal nucleic acid amplification technology market major players, and isothermal nucleic acid amplification technology market size.
View Complete Report:https://www.thebusinessresearchcompany.com/report/isothermal-nucleic-acid-amplification-technology-inaat-global-market-report The isothermal nucleic acid amplification technology market report provides an in-depth analysis of the impact of COVID-19 on the global isothermal nucleic acid amplification technology industry, along with revised market numbers due to the effects of the coronavirus and the expected isothermal nucleic acid amplification technology market growth numbers 2021-2030.
Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2021 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
Request For The Sample Now: https://www.thebusinessresearchcompany.com/sample.aspx?id=2505=smp The global isothermal nucleic acid amplification technology market is expected to grow from $2.36 billion in 2020 to $2.62 billion in 2021 at a compound annual growth rate (CAGR) of 11%.
